Skip to main content
OpenTrials

Clinical trial condition

Clear-cell metastatic renal cell carcinoma

Explore clinical trials studying Clear-cell metastatic renal cell carcinoma. Study availability and eligibility vary by location and protocol.

52 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Clear-cell metastatic renal cell carcinoma trial results

Recruiting

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

NCT05361720

Conditions
Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Recruiting

CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk

NCT07615348

Conditions
Clear-cell metastatic renal cell carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
Locations
  • Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing, Jiangsu, China
  • Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China
  • The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
  • Sir Run Run Hospital, Nanjing Medical University Nanjing, Jiangsu, China
View Trial Details
Recruiting

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

NCT07195682

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NCT07300241

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
Locations
  • NEO-811 Los Angeles Site Duarte, California, United States
  • NEO-811 San Diego Site San Diego, California, United States
  • NEO-811 Connecticut Site New Haven, Connecticut, United States
  • NEO-811 Chicago Site Zion, Illinois, United States
View Trial Details
Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

NCT07011719

Conditions
Advanced Clear Cell Renal Cell Carcinoma, Clear-cell metastatic renal cell carcinoma, Female Urogenital Diseases, +11 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Goodyear, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Duarte, California, United States
View all 159 locations
View Trial Details

Related conditions